Why Evolus (EOLS) Might Surprise This Earnings Season
Investors are always looking for stocks that are poised to beat at earnings season and Evolus, Inc. EOLS may be one such company. The firm has earnings coming up pretty soon, and events are shaping more...
Conformis, Inc. Announces 510(k) Clearance for Identity Imprint(TM) Knee Replacement System
Leveraging Conformis’ extensive library of personalized knee design data and patient images, Identity Imprint is designed to match patients’ anatomy with an optimal arthroplasty solution while at the same time offering greater efficiency, cost savings, more...
CENTOGENE Extends Global Parkinson’s Disease Study
Providing patients with genetic testing designed to accelerate the diagnosis and personalized treatment of Parkinson’s disease (PD) The Rostock International Parkinson’s Disease (ROPAD) Study aims to characterize the genetics of PD to establish a better more...
ReWalk Robotics to Report First Quarter 2021 Financial Results on May 11, 2021
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, May 07, 2021 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its first quarter 2021 financial more...
SeaSpine Announces Change of Annual Meeting to Virtual Meeting
CARLSBAD, Calif., May 07, 2021 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that, in response to the more...
What’s in Store for Asensus Surgical’s (ASXC) Q1 Earnings?
Asensus Surgical, Inc. ASXC is scheduled to release first-quarter 2021 results on May 11, after the closing bell. In the last reported quarter, the company reported a loss of 9 cents per share, narrower than more...
Motus GI Announces Publication of a Pure-Vu System® Cost Effectiveness Analysis in the Journal of Cost Effectiveness and Resource Allocation
– – – – The article states Pure-Vu System is estimated to provide lifetime saving of $833- $992 per patient when compared to standard of care for outpatient colorectal cancer (CRC) screening and surveillance colonoscopy more...
Centogene (CNTG) Enters Oversold Territory
Centogene N.V. CNTG has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some more...
Neovasc (NVCN) Reports Q1 Loss, Lags Revenue Estimates
Neovasc (NVCN) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.38 per share a year ago. These figures more...
T2 Biosystems (TTOO) Reports Q1 Loss, Tops Revenue Estimates
T2 Biosystems (TTOO) came out with a quarterly loss of $0.07 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.22 per share a year ago. These figures are adjusted more...